fda bpc-157 compounding category 2 bulk drug substances list Major peptide regulatory news this week. The BPC-157 FDA Approval Status 2026:
Description
No, neither form is universally better. Injectable BPC-157 is superior for systemic issues like muscle or tendon injuries due to its high bioavailability
In research, its of interest because it activates the same receptor as Luteinizing Hormone (LH) the LH/CG receptor which plays a central role in reproductive biology and hormonal regulation
They will then be randomly allocated to either active FMT therapy or placebo for 8 weeks
The 15 mg starter vial is $80 with a $39 medical visit fee
